Tice Bcg Drug Interactions: 209 Major, 99 Moderate
Tice Bcg (Bacillus Calmette-Guerin) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tice Bcg. Always confirm against the full prescribing information.
100 interactions
Abacavir
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Abacavir.
Level 2 evidence
Acyclovir
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Acyclovir.
Level 2 evidence
Adefovir dipivoxil
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Adefovir dipivoxil.
Level 2 evidence
Ansuvimab
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Ansuvimab.
Level 1 evidence
Asunaprevir
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Asunaprevir.
Level 2 evidence
Atazanavir
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Atazanavir.
Level 2 evidence
Atoltivimab
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Atoltivimab.
Level 1 evidence
Baloxavir marboxil
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Baloxavir marboxil.
Level 2 evidence
Bamlanivimab
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Bamlanivimab.
Level 2 evidence
Betamethasone
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Betamethasone.
Level 1 evidence
Bictegravir
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Bictegravir.
Level 2 evidence
Brincidofovir
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Brincidofovir.
Level 2 evidence
Enter your NPI to unlock 67 major interactions for Tice Bcg
Tice Bcg (Bacillus Calmette-Guerin) has 312 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Tice Bcg (Bacillus Calmette-Guerin) has 209 major, 99 moderate, and 4 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tice Bcg. Always confirm against the full prescribing information.